Xov xwm - HUASHIL
Nrhiav cov xov xwm tshiab tshaj tawm thiab cov lus tshaj tawm MDS.
Xov Xwm Tshaj Tawm & Nqe Lus Qhia
Kev Tshawb Fawb Tshwj Xeeb: 2025 International Congress
Lub kaum hli ntuj 5, 2025
Viewpoint: Biological Frameworks of Parkinson's Disease
Txoj hauj lwm: Biological txhais, Staging, thiab Classification of Parkinson's Disease
Hlis ntuj nqeg 14, 2023
Txoj Haujlwm: Kev kuaj mob Parkinson's Disease
Lub peb hlis ntuj 1, 2023
Txoj hauj lwm: Unproven Cell-Based Therapies
Lub ob hlis ntuj 9, 2021
Cov Lus Qhia Tseem Ceeb: COVID-19
Tshaj tawm rau lub Rau Hli 2020
MDS Xov Xwm Archive
Qhib TxhuaKaw Txhua Yam
Kev tshawb fawb tshwj xeeb los ntawm International Congress - Cuaj hlis 27, 2024
Cuaj hlis 27, 2024
Kev tshawb fawb tshwj xeeb - 2023 International Congress
Featured abstracts:
- Kev kho mob ntshav qab zib qhia tau tias muaj peev xwm ua ib qho kev kho mob ntxiv rau tus kab mob Parkinson thaum ntxov
- Thawj Tunisian txoj kev tshawb fawb tshawb xyuas lub hnub nyoog pib rau kev hloov pauv biallelic hauv Huntington tus kab mob
- Tshuab kawm algorithm siv nyob rau hauv kev faib tic los ntawm non-tic txav
- Kev kawm tshuab muaj peev xwm pab tau kev kuaj mob hauv Parkinsonian syndromes
- Kev siv tshiab tshiab ntawm kev kawm tshuab kev kwv yees kwv yees kev ua haujlwm tsis zoo hauv Parkinson tus kab mob
- Kev nyab xeeb thiab kev ua tau zoo ntawm kev kho noob tau kawm hauv minipig nrog Huntington tus kab mob
- Peb lub hlis ntawm kev kho mob probiotic tau pom tias txo qis lub cev muaj zog thiab cov tsos mob tsis yog Parkinson tus kab mob
MDS phau ntawv xov xwm:
- MDS Task Force ntawm Pediatrics tshaj tawm cov lus pom zoo rau kev saib xyuas kev hloov pauv rau cov tub ntxhais hluas uas muaj teeb meem txav mus los
- Cov ntaub ntawv tshiab tau lees paub txog kev sib koom ua ke ntawm kev raug mob ntsig txog kev mob thiab kev txhim kho Parkinson tus kab mob hauv cov tub rog qub tub rog
Kev tshawb fawb tshwj xeeb los ntawm International Congress - Cuaj hlis 14, 2021
- Txo Qhov Zoo ntawm Lub Neej Hauv Cov Neeg Mob Parkinson's Disease of Minority Racial Groups
- Cov yam ntxwv ntawm tsev kho mob COVID-19 Cov neeg mob uas muaj tus kab mob Parkinson
- Tus nqi thiab qhov muaj yog cov teeb meem loj hauv kev kuaj kab mob rau cov neeg mob Parkinson's Disease
- Cov txiaj ntsig zoo ntawm α-synuclein Targeted Immunotherapy hauv Kev Kho Mob Thaum Ntxov Parkinson's Disease
- Kev txo qis ntawm LRRK2 hauv Tib Neeg Cerebrospinal Fluid nrog LRRK2 Me Molecule Inhibitors
- Cov txiaj ntsig tau los ntawm Theem 2 Txoj Kev Kawm Ntawm Qhov Tseem Ceeb Tremor Therapeutic Shows Txhim Kho Upper Limb Tremor
Kev tshawb fawb tshwj xeeb los ntawm Virtual Congress - Cuaj hlis 11-15, 2020
- Active Immunotherapeutic PD01A rau Parkinson's Disease Phase I Clinical Study
- Thaum Ntxov Inflammation raws li qhov muaj peev xwm ua rau muaj kev poob qis hauv Nigrostriatal Function
- Multicenter, Deep Brain Stimulation Study pom zoo kom muaj ntau qhov kev txhawb nqa kom muaj txiaj ntsig zoo siv kev taw qhia vs. Omnidirectional Leads
- Lub Koom Haum ntawm Kev Kho Siab nrog Kev Ua Neej Zoo thiab Kab Mob hnyav hauv Parkinson's Disease
Kev tshawb fawb tshwj xeeb los ntawm International Congress - Cuaj hlis 22-26, 2019 (Nice, Fabkis)
- Lower Serum Biomarkers Pom nyob rau hauv Early Untreated Parkinson's Disease
- Kev cob qhia siab siv sijhawm ntev yuav nce qib BDNF hauv cov neeg mob Parkinson's Disease
- Kev Tshawb Fawb Thoob Ntiaj Teb Online Lub Hom Phiaj txhawm rau txheeb xyuas txoj hauv kev tshiab rau kev sib koom tes thoob ntiaj teb rau Parkinson's Disease
- Tus neeg mob txoj kev xaav ntawm tsis yog lub cev muaj zog thiab lub cev muaj zog ua tau zoo ua qauv Parkinson tus kab mob hnyav
- Kev nyab xeeb thiab Biomarker Cov teebmeem ntawm Novel Therapeutic rau Parkinson's Disease nrog GBA Mutations
Kev tshawb fawb tshwj xeeb los ntawm International Congress - Cuaj hlis 15, 2022
- Kev tshawb fawb luv luv ntawm Ecopipam Qhia Txog Kev txo qis ntawm Tics hauv Cov Me Nyuam nrog Tourette Syndrome
- Txawm li cas los xij, kev tawm dag zog txhim kho lub neej zoo thiab lub cev muaj zog ua haujlwm hauv cov neeg mob Parkinson's Disease
- Kev nce toj tau pom los txhim kho tus cwj pwm hauv cov neeg mob Parkinson's Disease
- Cov txiaj ntsig tau los ntawm Kev Tshawb Fawb PPMI ntawm Kev Ntsuas Alpha-Synuclein Seed Amplification Assay
- Kev Siv Circadian Intracerebroventricular Kev Tswj Xyuas Nruam ntawm Anaerobic-Dopamine Txo Cov Teeb Meem Txog Levodopa
- Cov txiaj ntsig tau los ntawm Phase III Clinical Trial rau Subcutaneous Infusion ntawm Foslevodopa / Foscarbidopa
Rau Media
Hais txog MDS
Lub International Parkinson thiab Movement Disorder Society (MDS), lub koom haum thoob ntiaj teb ntawm ntau dua 11,000 tus kws kho mob, kws tshawb fawb, thiab lwm tus kws kho mob, tau mob siab rau kev txhim kho cov neeg mob los ntawm kev kawm thiab kev tshawb fawb. Nyeem ntxiv txog MDS »
MDS's Apparent Authority Policy (PDF)
Xa daim ntawv thov lub logo rau International Secretariat (PDF)
Sib Cuag
Shea Higgins, Assistant Director of Communications
International Parkinson thiab Movement Disorder Society
555 E. Wells Street - Suite 1100
Milwaukee, WI 53202 USA
Tel: + 1 414-276-2145
Fax: + 1 414-276-3349
E-mail: shiggins@movementdisorders.org
Tag nrho lwm cov lus nug: info@movementdisorders.org